AKT1 and colorectal cancer: In fact, over activation and crosstalk of parallel pathways like phosphatidylinositol 3-kinase (PI3 kinase) – AKT with MAPK in colorectal cancer is playing a main role in the observed different response to BRAF inhibitor treatments in colorectal cancer.